SETDB1-IN-1

Overview

SETDB1-IN-1 is a SETDB1 inhibitor with an IC 50 of 16 μM. SETDB1-IN-1 inhibits histone methyltransferase ) activity via SAM-competitive and peptide-dependent mechanisms. SETDB1-IN-1 is applicable to research related to melanoma, lung cancer , liver cancer , breast cancer and prostate cancer .

Application

Products | Products > Disease Areas > Melanoma | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Methyltransferase

Product Information

• Catalog No.: HY-185849
• CAS No.: 2585194-96-1
• Molecular Formula: C12H18ClFN6O2S
• Molecular Weight: 364.83
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source